Wu Sun

2.0k total citations
26 papers, 989 citations indexed

About

Wu Sun is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Wu Sun has authored 26 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Cancer Research and 7 papers in Surgery. Recurrent topics in Wu Sun's work include MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (10 papers) and Circular RNAs in diseases (8 papers). Wu Sun is often cited by papers focused on MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (10 papers) and Circular RNAs in diseases (8 papers). Wu Sun collaborates with scholars based in China, Taiwan and Czechia. Wu Sun's co-authors include Haiyang Zhang, Yi Ba, Jialu Li, Yanqing Liu, Chen‐Yu Zhang, Jiayi Han, Xi Chen, Zheng Fu, Xiaorui Chen and Likun Zhou and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Molecular Cancer.

In The Last Decade

Wu Sun

25 papers receiving 977 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wu Sun China 15 784 665 79 77 61 26 989
Shuiyi Liu China 16 727 0.9× 651 1.0× 89 1.1× 108 1.4× 121 2.0× 23 991
Yilin Hu China 13 555 0.7× 472 0.7× 49 0.6× 84 1.1× 60 1.0× 32 710
Abraham Pedroza‐Torres Mexico 13 595 0.8× 524 0.8× 25 0.3× 75 1.0× 43 0.7× 25 790
Yongjian Gao China 16 406 0.5× 287 0.4× 46 0.6× 72 0.9× 48 0.8× 39 685
Ningjing Lei China 16 453 0.6× 272 0.4× 23 0.3× 111 1.4× 111 1.8× 38 691
Changhao Liu China 15 366 0.5× 204 0.3× 29 0.4× 110 1.4× 55 0.9× 46 682
Duo Wen China 18 513 0.7× 361 0.5× 43 0.5× 106 1.4× 60 1.0× 36 848
Jia‐Yin Tang China 12 570 0.7× 431 0.6× 38 0.5× 105 1.4× 56 0.9× 17 791

Countries citing papers authored by Wu Sun

Since Specialization
Citations

This map shows the geographic impact of Wu Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wu Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wu Sun more than expected).

Fields of papers citing papers by Wu Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wu Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wu Sun. The network helps show where Wu Sun may publish in the future.

Co-authorship network of co-authors of Wu Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Wu Sun. A scholar is included among the top collaborators of Wu Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wu Sun. Wu Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Xiaofeng, Wu Sun, Qin Liu, et al.. (2024). Design of a single-center, phase II trial to explore the efficacy and safety of ‘R-ISV-RO’ treatment in advanced tumors. Future Oncology. 20(17). 1139–1149. 2 indexed citations
2.
Sun, Wu, et al.. (2024). Comprehensive analysis of zinc and ring finger 3 in prognostic value and pan‐cancer immunity. The FASEB Journal. 38(5). e23523–e23523. 1 indexed citations
3.
Wang, Baojian, et al.. (2021). The increased motion of lumbar induces ligamentum flavum hypertrophy in a rat model. BMC Musculoskeletal Disorders. 22(1). 334–334. 14 indexed citations
4.
Liang, Hongwei, Wu Sun, Jialu Li, et al.. (2021). Author Correction: Deregulation of the miR-16-KRAS axis promotes colorectal cancer. Scientific Reports. 11(1). 19841–19841. 1 indexed citations
5.
Han, Jiayi, Wu Sun, Rui Liu, et al.. (2020). Plasma Exosomal miRNA Expression Profile as Oxaliplatin-Based Chemoresistant Biomarkers in Colorectal Adenocarcinoma. Frontiers in Oncology. 10. 1495–1495. 29 indexed citations
6.
Sun, Wu, Jialu Li, Likun Zhou, et al.. (2020). The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer. Theranostics. 10(5). 1981–1996. 107 indexed citations
7.
Meng, Xiangfeng, Wu Sun, Jing Yu, et al.. (2020). LINC00460-miR-149-5p/miR-150-5p-Mutant p53 Feedback Loop Promotes Oxaliplatin Resistance in Colorectal Cancer. Molecular Therapy — Nucleic Acids. 22. 1004–1015. 43 indexed citations
8.
Liu, Tianyao, Qun Lu, Jin Liu, et al.. (2020). Circular RNA FAM114A2 suppresses progression of bladder cancer via regulating ∆NP63 by sponging miR-762. Cell Death and Disease. 11(1). 47–47. 37 indexed citations
9.
Ge, Shaohua, Haiyang Zhang, Ting Deng, et al.. (2019). MiR-181a, a new regulator of TGF-β signaling, can promote cell migration and proliferation in gastric cancer. Investigational New Drugs. 37(5). 923–934. 12 indexed citations
10.
Sun, Wu, Wei Xiao, Zhenzhong Wang, et al.. (2019). Compression therapy following posterior lumbar interbody fusion: a prospective, randomized, clinical study. BMC Surgery. 19(1). 161–161.
11.
Yang, Man, et al.. (2018). Down-regulation of miR-203a by lncRNA PVT1 in multiple myeloma promotes cell proliferation. Archives of Medical Science. 14(6). 1333–1339. 37 indexed citations
12.
Wang, Nan, Shuang Qu, Wu Sun, et al.. (2018). Direct quantification of 3′ terminal 2′-O-methylation of small RNAs by RT-qPCR. RNA. 24(11). 1520–1529. 15 indexed citations
13.
Liu, Yanqing, Xiaorui Chen, Rongjie Cheng, et al.. (2018). The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer. Molecular Cancer. 17(1). 11–11. 99 indexed citations
14.
Sun, Wu, Xiaojun Wang, Jialu Li, et al.. (2018). MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathway. Cell Death and Disease. 9(4). 438–438. 81 indexed citations
15.
Liu, Yanqing, Rui Liu, Fei Yang, et al.. (2017). miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1. Molecular Cancer. 16(1). 53–53. 158 indexed citations
16.
Zhang, Haiyang, Yi Wang, Ming Bai, et al.. (2017). Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA. Cancer Science. 109(3). 629–641. 127 indexed citations
17.
Liang, Hongwei, Wu Sun, Jialu Li, et al.. (2016). Deregulation of the miR-16-KRAS axis promotes colorectal cancer. Scientific Reports. 6(1). 37459–37459. 31 indexed citations
18.
Fan, Qian, Xiangrui Meng, Hongwei Liang, et al.. (2016). miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma. Protein & Cell. 7(12). 899–912. 41 indexed citations
19.
Hong, Yeting, Cheng Wang, Zheng Fu, et al.. (2016). Systematic characterization of seminal plasma piRNAs as molecular biomarkers for male infertility. Scientific Reports. 6(1). 24229–24229. 76 indexed citations
20.
Sun, Wu, et al.. (2012). [Comparison of two techniques in hemivertebra resection: anterior- posterior approach versus posterior approach].. PubMed. 92(11). 756–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026